The downregulation of stearoyl-coenzyme A desaturase-1 (SCD1), and the enhancement of insulin and leptin sensitivity have been suggested as a curative measures in HFD-induced obesity [97,102,105]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.